- strain: CU1546
Caenorhabditis elegans - strain: NK1531
Caenorhabditis elegans - strain: NK1532
Caenorhabditis elegans - strain: DCL569
Caenorhabditis elegans - gene: F52E1.2 [Browse genome (BioProject PRJNA13758)] [Search on AGR]
Caenorhabditis elegans Predicted to enable carbohydrate binding activity. Predicted to be located in external side of plasma membrane. Expressed in amphid sheath cell and phasmid sheath cell. Human ortholog(s) of this gene implicated in several diseases, including acquired immunodeficiency syndrome; bronchopulmonary dysplasia; and tuberculosis (multiple). Is an ortholog of several human genes including ASGR1 (asialoglycoprotein receptor 1); CD209 (CD209 molecule); and FCER2 (Fc epsilon receptor II).
- gene: clec-149 [Browse genome (BioProject PRJNA13758)] [Search on AGR]
Caenorhabditis elegans Predicted to enable carbohydrate binding activity. Predicted to be located in external side of plasma membrane. Human ortholog(s) of this gene implicated in several diseases, including acquired immunodeficiency syndrome; bronchopulmonary dysplasia; and tuberculosis (multiple). Is an ortholog of human CD209 (CD209 molecule) and FCER2 (Fc epsilon receptor II).
- expression cluster: WBPaper00060273:isp-1(qm150)_upregulated
EdgeR, FC < 0.5 or FC > 2.0, p<0.001.
Transcripts that showed significantly increased expression in isp-1(qm150) comparing to in N2 animals.
- expression cluster: WBPaper00060273:vrk-1(RNAi)_upregulated
EdgeR, FC < 0.5 or FC > 2.0, p<0.001.
Transcripts that showed significantly increased expression in isp-1(qm150);vrk-1(RNAi) comparing to in isp-1(qm150) animals.
- expression cluster: WBPaper00060273:vrk-1(RNAi)_downregulated
EdgeR, FC < 0.5 or FC > 2.0, p<0.001.
Transcripts that showed significantly decreased expression in isp-1(qm150);vrk-1(RNAi) comparing to in isp-1(qm150) animals.